Because the measurement of low concentrations of CRP is critical for early diagnosis of inflammation and cardiovascular disease, many researchers have attempted to develop a highly sensitive CRP-detectable LFIA [19–21]. The gene discussed is CRP; the disease is cardiovascular disorder.